Press Releases
Lipella Pharmaceuticals Press Releases
A Message from Our CEO, Dr. Jonathan Kaufman
Press Releases A Message from Our CEO, Dr. Jonathan Kaufman - Expanding Our Clinical Pipeline to Target Serious and Rare Diseases As the CEO of Lipella Pharmaceuticals, I am proud to share [...]
Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial
Press Releases Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial PITTSBURGH, Jan. 11, 2023 /MarketWatch/ Lipella Pharmaceuticals Inc. said it saw positive top-line results from its recently completed Phase 2a clinical trial [...]
Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock
Press Releases Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock PITTSBURGH, Dec. 19, 2022 /PRNewswire/ — Lipella Pharmaceuticals, Inc. (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company focused on developing [...]
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry
Press Releases Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry for people affected by pelvic radiation during cancer treatment Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation [...]
Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate
Press Releases Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate Pittsburgh, PA – (May 11, 2021) – Lipella Pharmaceuticals Inc., a clinical stage [...]
Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy
Press Releases Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy Pittsburgh, PA – (April 30, 2021) – The Bladder Health Foundation announces the rollout of the first on-line [...]
National Bladder Awareness Month: A Look at the Facts about Pelvic Radiation Cancer Survivors
Press Releases National Bladder Awareness Month: A Look at the Facts about Pelvic Radiation Cancer Survivors Lipella Pharmaceuticals promotes awareness of hemorrhagic cystitis, a chronic painful syndrome that can be acquired by [...]
Lipella Pharmaceuticals Initiates its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis
Press Releases Lipella Pharmaceuticals Initiates its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis A multi-site, prospective, open-label, dose-escalation clinical trial assessing the safety and efficacy of LP-10 (liposomal tacrolimus) is now [...]
Reach Out